Stock Evaluator: Connect Biopharma Holdings Limited (CNTB)

Connect Biopharma Holdings Limited CNTB

$0.68 0.01 1.79%
November 13, 2026 4:00:00 PM EST November 10, 2021 Volume: 233,834
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Biotechnology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.

Commentary & Analysis


Financial Summary

Share Statistics CNTB Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $42.6 $211.8 16%
Shares Out (Mil) 62.9 55.4 53%
Institutional Ownership 61.1% 93.0% 39%
Float (Mil) 22.1 41.5 30%
Beta na 0.99 na
Avg Daily Volume (000s) 315 553 50%
Price Change
(52-week)
(57.9%) 42.8% 17%
Growth CNTB Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 13.2% na
Net Income (5yr) 14.2% (10.3%) 62%
EPS (5yr) 32.2% 15.8% 83
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) (15.1%) (15.7%) 51%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 5 5 5
Current EPS ($0.258) ($0.976) ($0.772)
Month Ago EPS ($0.258) ($0.976) ($0.772)
# Rev Up 0 2 2
# Rev Down 0 0 0
Three Months Ago EPS ($0.260) ($1.002) ($0.746)
Year/Year Chg (6.2%) (2.1%) (43.0%)
Financials CNTB Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $3 $41 4%
Net Income (TTM) (Mil) ($69) ($44) 14%
EPS (TTM) ($1.193) ($1.500) 19%
Operating Cash Flow (TTM) (Mil) ($61) ($35) 9%
Net Cash Flow (TTM) (Mil) ($14) $-0 31%
Long-Term Debt (Q1) (Mil) $0 $4 12%
Enterprise Value (Q1) (Mil) $18 $147 11%
Valuation CNTB Industry
Median
Percentile
(All Stocks)
P/B 1.57 2.01 45%
P/E na 17.9 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.0 na
Ratios CNTB Industry
Median
Percentile
(All Stocks)
Gross Margin 100.0% 67.9% 96%
Net Margin na (50.6%) na
ROA (109.3%) (47.4%) 5%
ROE (140.5%) (53.1%) 6%
Liabilities to Assets 38.2% 29.7% 29%
F-Score 2 3 7%

Connect Biopharma Holdings Limited did not pass any screens on 11/13/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors